Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > We were counted as down and out 8 months ago, we were never

<< Previous

Bullboard Posts

Next >>

Comment by Maxdudeon Mar 03, 2021 2:44pm

109 Views

Post# 32706901

RE:RE:RE:RE:RE:RE:RE:RE:We were counted as down and out 8 months ago, we were never

Come on folks we are here to make some decent $$

If you are not interested in that...then you have lots of time come on a BB and post.

Never understand why some folks just knock stock when they are not in it....maybe it's just their way of getting off...lol

I am here to make some decent $...willing to give Mgmt some time to put this puzzle together....they just start trading.

If they are successfull....the Market cap will expand massively!!!! And my Bank Account!!

<< Previous

Bullboard Posts

Next >>

Hyundai partners with BlackBerry for next-gen digital cockpit platform